Effects of medicare part D coverage gap on medication adherence

American Journal of Managed Care

Volumn 19, Issue 6, 2013, Pages

  Zhang, Yuting ^a   Baik, Seo Hyon ^a   Lave, Judith R ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CARDIAC AGENT;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG USE; HEART FAILURE; HUMAN; INSURANCE; MEDICARE; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; PRETEST POSTTEST DESIGN; PRIORITY JOURNAL; PROBABILITY; PROPENSITY SCORE;

AGED; CONFIDENCE INTERVALS; DIABETES MELLITUS; DRUGS, GENERIC; HEART FAILURE; HUMANS; INSURANCE COVERAGE; INSURANCE, MEDIGAP; MEDICARE PART D; MEDICATION ADHERENCE; PROPENSITY SCORE; UNITED STATES;

EID: 84880454006     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Zhang Y, Donohue JM, Lave JR, O'Donnell G, Newhouse JP. The effect of Medicare Part D on drug and medical spending. N Engl J Med. 2009;361(1):52-61.
2. Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care. 2010;48(5):409-417.
3. Ketcham JD, Simon KI. Medicare Part D's effects on elderly patients' drug costs and utilization. Am J Manag Care. 2008;14(11)(suppl):SP14-SP22.
4. Kaiser Family Foundation. The Medicare Prescription Drug Benefit Fact Sheet. http://kff.org/medicare/upload/7044- 06.pdf. Published 2007. Accessed July 10, 2011.
5. Centers for Medicare & Medicaid Services. Medicare Part D data symposium presentations. http://www.cms.gov/PrescriptionDrugCov-GenIn/09- ProgramReports.asp. Published 2010. Accessed February 3, 2011.
6. Schmittdiel JA, Ettner SL, Fung V, et al. Medicare Part D coverage gap and diabetes beneficiaries. Am J Manag Care. 2009;15(3):189-193.
7. Zhang Y, Donohue JM, Newhouse JP, Lave JR. The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Aff (Millwood). 2009;28(2):w317-w325.
8. Schneeweiss S, Patrick AR, Pedan A, et al. The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff (Millwood). 2009;28(2):w305-w316.
9. Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22):2349-2359.
10. Raebel MA, Delate T, Ellis JL, Bayliss EA. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D. Med Care. 2008;46(10):1116-1122.
11. Nair KV, Frech-Tamas F, Jan S, Wolfe P, Allen RR, Saseen JJ. Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan. J Health Care Finance. 2011;38(2):38-53.
12. Duru OK, Mangione CM, Hsu J, et al. Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study. J Am Geriatr Soc. 2010;58(5):822-828.
13. Gu Q, Zeng F, Patel BV, Tripoli LC. Part D coverage gap and adherence to diabetes medications. Am J Manag Care. 2010;16(12):911-918.
14. Fung V, Mangione CM, Huang J, et al. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes. Health Serv Res. 2010;45(2):355-375.
15. Li P, McElligott S, Bergquist H, Schwartz JS, Doshi JA. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia. Ann Intern Med. 2012;156(11):776-784.
16. Polinski JM, Shrank WH, Glynn RJ, Huskamp HA, Roebuck MC, Schneeweiss S. Beneficiaries with cardiovascular disease and the Part D coverage gap. Circ Cardiovasc Qual Outcomes. 2012;5(3):387-395.
17. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):e391-479.
18. Brown AF, Mangione CM, Saliba D, Sarkisian CA; California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5)(suppl guidelines):S265-S280.
19. Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG. The effect of incentive-based formularies on prescriptiondrugnutilization and spending. N Engl J Med. 2003;349(23):2224-2232.
20. Huskamp HA, Frank RG, McGuigan KA, Zhang Y. Impact of a threetiermformulary on demand response for prescription drugs. J EconmManage Strategy. 2005;14(3):729-753.
21. Kaiser Family Foundation. Medicare Part D 2010 Data Spotlight:the Coverage Gap. http://kff.org/medicare/upload/8008.pdf. Published October 2009. Accessed April 22, 2011.
22. Meyer BD. Natural and quasi-experiments in economics. J Business Econ Stat. 1995;13:151-161.
23. Elixhauser A, Steiner C, Harris D, Coffey RM. Comorbidity measuresmfor use with administrative data. Med Care. 1998;36(1):8-27.
24. Centers for Medicare & Medicaid Services. Prescription Drug Hierarchical Condition Category (RxHCC) model software. http://www.cms.gov/ Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Risk-adjustment-prior.html. Published June 2010. Accessed February 3, 2010.
25. Kaiser Family Foundation. Summary of Key Changes to Medicare in 2010 Health Reform Law. http://kff.org/health-reform/issue-brief/summary-of-key- changes-to-medicare-in. Published April 2010. Accessed July 10, 2011.
26. Kaiser Family Foundation. The Medicare Prescription Drug Benefit. 2010; http://kff.org/medicare/upload/7044- 11.pdf. Accessed July 10, 2011.